EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FoxG1 as a Potential Therapeutic Target for Alzheimer’s Disease: Modulating NLRP3 Inflammasome via AMPK/mTOR Autophagy Pathway

Qi Yun, Si-Fei Ma, Wei-Ning Zhang, Meng Gu, Jia Wang

Cellular and Molecular Neurobiology · 2024-12 · 44 (1)

DOI: 10.1007/s10571-024-01467-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular and Molecular Neurobiology, online erschienen am 17.04.2024. Verfasst von Qi Yun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Changzhou Children's Hospital Affiliated to Nantong University, 958 Zhongwu Avenue, Changzhou, 213000, Jiangsu Province, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Inflammasomes, Forkhead Transcription Factors. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Basic Research Project of Changzhou, Station level project of Changzhou Blood Center, Clinic Development Fund of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An increasing body of research suggests that promoting microglial autophagy hinders the neuroinflammation initiated though the NLRP3 inflammasome activation in Alzheimer’s disease (AD). The function of FoxG1, a crucial transcription factor involved in cell survival by regulating mitochondrial function, remains unknown during the AD process and neuroinflammation occurs. In the present study, we firstly found that Aβ peptides induced AD-like neuroinflammation upregulation and downregulated the level of autophagy. Following low-dose Aβ25–35 stimulation, FoxG1 expression and autophagy exhibited a gradual increase. Nevertheless, with high-concentration Aβ25–35 treatment, progressive decrease in FoxG1 expression and autophagy levels as the concentration of Aβ25–35 escalated. In addition, FoxG1 has a positive effect on cell viability and autophagy in the nervous system. In parallel with the Aβ25–35 stimulation, we employed siRNA to decrease the expression of FoxG1 in N2A cells. A substantial reduction in autophagy level (Beclin1, LC3II, SQSTM1/P62) and a notable growth in inflammatory response (NLRP3, TNF-α, and IL-6) were observed. In addition, we found FoxG1 overexpression owned the effect on the activation of AMPK/mTOR autophagy pathway and siRNA-FoxG1 successfully abolished this effect. Lastly, FoxG1 suppressed the NLRP3 inflammasome and enhanced the cognitive function in AD-like mouse model induced by Aβ25–35. Confirmed by cellular and animal experiments, FoxG1 suppressed NLRP3-mediated neuroinflammation, which was strongly linked to autophagy regulated by AMPK/mTOR. Taken together, FoxG1 may be a critical node in the pathologic progression of AD and has the potential to serve as therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseInflammasomesForkhead Transcription FactorsAnimalsMiceAMP-Activated Protein KinasesAutophagyNeuroinflammatory DiseasesNLR Family, Pyrin Domain-Containing 3 ProteinRNA, Small InterferingNerve Tissue Proteins

Stichwörter der Autor:innen

AMPK/mTORAlzheimer’s diseaseAutophagyFoxG1NLRP3β-amyloid

Substanzen

AMP-Activated Protein KinasesInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinRNA, Small InterferingForkhead Transcription FactorsFOXG1 protein, humanNerve Tissue Proteins

Autor:innen und Institutionen

  • Changzhou Children's Hospital Affiliated to Nantong University, 958 Zhongwu Avenue, Changzhou, 213000, Jiangsu Province, China.
  • Changzhou Blood Center, 118 Canal Road, Changzhou, 213000, Jiangsu Province, China.
  • Department of Laboratory Medicine, School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, 213000, Jiangsu Province, China.
  • Changzhou Children's Hospital Affiliated to Nantong University, 958 Zhongwu Avenue, Changzhou, 213000, Jiangsu Province, China. 1041152404@qq.com.
  • Department of Laboratory Medicine, School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, 213000, Jiangsu Province, China. wangjia@ujs.edu.cn.
  • The Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, Jiangsu Province, PR China. wangjia@ujs.edu.cn.

Förderung

  • Applied Basic Research Project of Changzhou
  • Station level project of Changzhou Blood Center
  • Clinic Development Fund of Jiangsu Province

Zitieren

APA

Yun, Q., Ma, S. F., Zhang, W. N., Gu, M., & Wang, J. (2024). FoxG1 as a Potential Therapeutic Target for Alzheimer’s Disease: Modulating NLRP3 Inflammasome via AMPK/mTOR Autophagy Pathway. Cellular and Molecular Neurobiology, 44(1). https://doi.org/10.1007/s10571-024-01467-4

Vancouver

Yun Q, Ma SF, Zhang WN, Gu M, Wang J. FoxG1 as a Potential Therapeutic Target for Alzheimer’s Disease: Modulating NLRP3 Inflammasome via AMPK/mTOR Autophagy Pathway. Cellular and Molecular Neurobiology. 2024;44(1). doi:10.1007/s10571-024-01467-4

BibTeX
@article{Yun2024,
  author = {Yun, Qi and Ma, Si-Fei and Zhang, Wei-Ning and Gu, Meng and Wang, Jia},
  title = {FoxG1 as a Potential Therapeutic Target for Alzheimer’s Disease: Modulating NLRP3 Inflammasome via AMPK/mTOR Autophagy Pathway},
  journal = {Cellular and Molecular Neurobiology},
  year = {2024},
  volume = {44},
  number = {1},
  doi = {10.1007/s10571-024-01467-4}
}
Kostenlos starten →